Induction of labor: Clinical sciences

Last updated: January 30, 2025

Induction of labor: Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Induction of labor is the initiation of parturition through the use of medications and other processes that mimic normal labor. This procedure can be done when the benefits of delivery outweigh the risks of continuing a pregnancy. Depending on the patient’s initial cervical exam, you may need to ripen the cervix or stimulate contractions with a variety of methods. Ultimately the goal of labor induction is to have a spontaneous vaginal delivery.

Okay, when a pregnant patient presents for induction of labor, you should assess if there are any contraindications present before doing anything.

Contraindications are conditions that prevent a safe vaginal delivery, such as transverse fetal lie, non-reassuring fetal status, or umbilical cord prolapse.

Here’s a clinical pearl! An umbilical cord prolapse occurs when the umbilical cord falls below the presenting part of the fetus, usually through a dilated cervix into the vagina. This is an obstetric emergency that needs immediate C-section delivery!

Additional contraindications include patients with previous disruption of the myometrium, including a prior classical c-section with a uterine incision, a prior myomectomy entering the uterine cavity, or a prior uterine rupture. These patients are at a high risk of uterine rupture during labor, which makes induction inadvisable.

Additionally, some patients may have abnormal placentation, such as a placenta previa, where the placenta covers the cervical os and bleeds profusely if cervical dilation occurs; as well as abnormal vascular presentation like vasa previa, where the umbilical vessels are unprotected and found in the membranes that cover the cervical os. Others may have conditions such as invasive cervical cancer, which can block the cervical os and obstruct the ability of a fetus to pass through the birth canal, while also increasing the risk of severe maternal hemorrhage.

Another contraindication is an active viral disease that can be passed to the fetus during delivery. This includes an HIV viral load of more than 1000 in the third trimester; or an active herpes simplex virus infection, specifically, if HSV lesions are present in the genitourinary tract or if a patient experiences prodromal symptoms like genital burning or pain.

Finally, do not induce patients with a gestational age less than 39 weeks, unless they have a medical indication for delivery, like preeclampsia. Elective induction can be performed at 39 weeks if gestational age has been confirmed.

Here’s a clinical pearl to keep in mind! Fetal morbidity increases starting at 41 weeks, so induction of labor should be revisited with patients who haven’t yet delivered by that time, and induction of labor is definitely recommended if spontaneous labor has not begun by 42 weeks due to the increased risk of stillbirth.

Okay, if a contraindication is present, do not proceed with induction of labor. Instead, consider c-section delivery or in cases of fetal malpresentation, an external cephalic version may be attempted. On the other hand, if contraindications are absent you can proceed with an induction of labor. Your first step is to perform a cervical exam and calculate the Bishop score.

Let’s look at how to proceed once we calculate the Bishop score.

This is a scoring system based on a set of criteria noted on the vaginal exam that predicts the likelihood of successful induction of labor. The Bishop score is helpful in deciding how to start an induction. There are five criteria to consider: cervical dilation, which describes how many centimeters open the cervix is; the position of the cervix within the vaginal canal; the effacement of the cervix indicating how thin the cervix is; the station of the fetal head within the pelvis; and the consistency of the cervix, which softens as labor begins. Each one is given from 0 to 3 points, and the total value is known as the Bishop score. Of note, cervical dilation is considered the most important of the five scoring elements.

Let’s first look at an unfavorable Bishop score. If the Bishop score is 6 or less, the cervix is considered unfavorable. This means you will need to perform cervical ripening before the induction process. In normal parturition, the cervix will soften, thin, dilate, and move anteriorly. Cervical ripening facilitates that process, which increases the likelihood of a successful induction of labor. This can be done with pharmacological agents or mechanical methods of cervical ripening.

The most commonly used ripening agent is a synthetic prostaglandin E1 analogue called misoprostol. It can be administered either by mouth, buccally, or inserted into the vagina. In addition to ripening the cervix, misoprostol will stimulate uterine contractions. There is also a prostaglandin E2 analogue available called dinoprostone, which works similarly. Dinoprostone is available in a vaginal form only.

Here’s a clinical pearl! Even though prostaglandins increase the likelihood of vaginal delivery within 24 hours, they actually don’t reduce the rate of C-section delivery, and there’s an increased risk of uterine tachysystole. This is defined as more than five contractions in 10 minutes. If sustained, this can cause fetal distress and you may need to administer a tocolytic, like terbutaline, to relax the uterine muscle. Also, keep in mind that all prostaglandins are contraindicated in patients who had a prior c-section but who otherwise qualify for a trial of labor after C-section, as prostaglandin use raises the risk of rupture.

Sources

  1. "ACOG Practice Bulletin No. 107: Induction of Labor" Obstet Gynecol (2009)